Bacterial Pathogens in Cystic Fibrosis Group, Department of Infectious Diseases and Immunology, Central Clinical School, University of Sydney, Australia.
Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia.
Microbiology (Reading). 2013 Nov;159(Pt 11):2354-2363. doi: 10.1099/mic.0.066985-0. Epub 2013 Sep 6.
Chronic Pseudomonas aeruginosa infection is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients. P. aeruginosa isolates undergo significant transcriptomic and proteomic modulation as they adapt to the niche environment of the CF lung and the host defences. This study characterized the in vitro virulence of isogenic strain pairs of P. aeruginosa epidemic or frequent clonal complexes (FCCs) and non-epidemic or infrequent clonal complexes (IFCCs) that were collected 5-8 years apart from five chronically infected adult CF patients. Strains showed a significant decrease in virulence over the course of chronic infection using a Caenorhabditis elegans slow-killing assay and in phenotypic tests for important virulence factors. This decrease in virulence correlated with numerous differentially expressed genes such as oprG, lasB, rsaL and lecB. Microarray analysis identified a large genomic island deletion in the IFCC strain pair that included type three secretion system effector and fimbrial subunit genes. This study presents novel in vitro data to examine the transcriptomic profiles of sequentially collected P. aeruginosa from CF adults. The genes with virulence-related functions identified here present potential targets for new therapies and vaccines against FCCs and IFCCs.
慢性铜绿假单胞菌感染是囊性纤维化 (CF) 患者发病和死亡的主要原因。铜绿假单胞菌分离株在适应 CF 肺部的生态环境和宿主防御时,会经历显著的转录组和蛋白质组调节。本研究对从 5 到 8 年前分离自 5 名慢性感染成年 CF 患者的同基因流行或频繁克隆复合体 (FCC) 和非流行或不频繁克隆复合体 (IFCC) 的铜绿假单胞菌进行了体外毒力特征分析。使用秀丽隐杆线虫缓慢致死测定法和重要毒力因子的表型检测,菌株在慢性感染过程中的毒力显著降低。这种毒力下降与许多差异表达基因(如 oprG、lasB、rsaL 和 lecB)相关。微阵列分析在 IFCC 菌株对中发现了一个大型基因组岛缺失,其中包括 III 型分泌系统效应子和菌毛亚基基因。本研究提供了新的体外数据,用于检测从 CF 成人中连续采集的铜绿假单胞菌的转录组谱。这里确定的具有毒力相关功能的基因为针对 FCC 和 IFCC 的新疗法和疫苗提供了潜在的靶标。